Announcements - Translational Lung Cancer Research

Posted: 2017-07-18

Welcome to join us on IASLC 18th World Conference on Lung Cancer

Posted: 2017-04-18

Strategic Partnership Agreement between AME Publishing Company and Italian Society of Thoracic Surgery (SICT) is signed!

Posted: 2017-04-02

Welcome to the 4th Symposium on Thoracic and Upper Aerodigestive Malignancies

Posted: 2017-01-19

TLCR Annual Report (2016)

Posted: 2016-09-19

AME Publishing Company successfully closed Series A funding of 4 million USD

Posted: 2016-03-15

TLCR Annual Report (2015)

Posted: 2016-01-28

Translational Lung Cancer Research is endorsed by the Brazilian Society of Thoracic Surgery (SBCT)

Posted: 2015-11-08

Translational Lung Cancer Research is newly included by Scopus

It is great to share with all the readers that Translational Lung Cancer Research (TLCR) has been accepted for inclusion in Scopus since October 2015.

Posted: 2015-10-14

Welcome to join us at the 2015 ASTRO

We sincerely welcome you to visit our booth “AME Publishing Company” at No. 300 in Hall A. Look forward to meeting you in San Antonio!

Posted: 2015-08-07

Focused Issue: Improving the Quality and Outcomes of Lung Cancer Care: An Interdisciplinary Approach

The Focused Issue“Improving the Quality and Outcomes of Lung Cancer Care: An Interdisciplinary Approach”led by Prof. Raymond U. Osarogiagbon is published in the August Issue of Translational Lung Cancer Research.

Posted: 2015-08-06

Special Section "Controversies on Lung Cancer: Pros and Cons" is launched on Translational Lung Cancer Research

The Special Section “Controversies on Lung Cancer: Pros and Cons”chaired by Prof. Suresh Senan and Prof. Helmut H. Popper, is first launched in the August Issue (Vol 4, No 4) of the journal Translational Lung Cancer Research.

Posted: 2015-06-25

Testimonials for TLCR from Eminent Experts Worldwide

According to the latest Journal Citation Reports (JCR), TLCR has obtained its impact factor 4.806. Since founded in 2012, TLCR has spent seven years to become what it is today. We highly appreciate all the editorial board members, Guest Editors, authors, reviewers, and readers who have been supporting TLCR all the time.

Posted: 2015-06-24

‘Liquid biopsy’ able to detect early resistance to targeted therapy in advanced lung cancer patients

• Monitoring of EML4-ALK gene rearrangements in blood platelets is sufficiently sensitive and specific to be incorporated into clinical practice.
• Non-invasive blood samples can be taken repeatedly, overcoming the challenges associated with obtaining sufficient tumor tissue for genetic analyses.
• The ability to detect disease progression in ‘real time’ allows oncologists to predict treatment outcomes, switch therapies when necessary and increase life expectancy.

Posted: 2015-04-02

The textbook on Lung Cancer: time for personalized medicine

We are glad to announce that the book Lung Cancer is accomplished and launched recently by the AME Publishing Company.

Posted: 2015-01-21

Translational Lung Cancer Research is endorsed by the Bonnie J. Addario Lung Cancer Foundation

With the same ideal, Translational Lung Cancer Research (TLCR) is endorsed by the Bonnie J. Addario Lung Cancer Foundation (ALCF) from January 15, 2015.

Posted: 2015-01-01

Translational Lung Cancer Research is indexed by PubMed

On the early morning of December 31, 2014, a good news from PubMed Central has flown through the Editorial Office: Translational Lung Cancer Research (TLCR) has passed the evaluation and is officially indexed by PubMed! (figure 1) This is one more milestone for TLCR as an acknowledgment of its expansion and dedication to translational research of lung cancer and will tremendously advance its continued exploration in the field.

Posted: 2014-10-09

TLCR’s Upcoming Special Issue dedicated to The 14^th Central European Lung Cancer Congress (CELCC)

Co-Guest-Edited by Prof. Robert Pirker from Austria and Prof. Caicun Zhou from China, Translational Lung Cancer Research(TLCR) in October has successfully published a special issue(Vol 3, No 5) dedicated to the 14th Central European Lung Cancer Conference (CELCC) held in Vienna, Austria, from 29 November until 2 December 2014(https://www.mondial-congress.com/de/celcc2014).

Posted: 2014-09-10

Join us in The 56th American Society for Radiation Oncology (ASTRO) Annual Meeting in San Francisco, USA

The 56th American Society for Radiation Oncology (ASTRO) Annual Meeting (ASTRO 2014) will take place at the Moscone Center, San Francisco, CA, USA from September 14th to 17th, 2014. The conference is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year. This year’s meeting will highlight science that showcases how technology and biology advance the field and improve patient outcomes and quality of life.

Posted: 2014-05-06

Meet you in the 50^th American Society of Clinical Oncology (ASCO)

The 50^th Annual Meeting of American Society of Clinical Oncology (ASCO) is to be conducted at McCormick Place, Chicago, Illinois from May 30-June 3, 2014.

Posted: 2013-12-10

TLCR is endorsed by the Spanish Lung Cancer Group (SLCG): new horizons for strong academic collaboration in lung cancer

From November 1, 2013, Translational Lung Cancer Research (TLCR) is officially endorsed by the Spanish Lung Cancer Group (figure 1). This is a meaningful milestone for TLCR as an acknowledgment of its expansion and dedication to lung cancer research and will tremendously advance its continued exploration in the field.

Posted: 2013-07-24

Join us in the 15th World Conference on Lung Cancer in Sydney, Australia

The 15th World Conference on Lung Cancer (WCLC 2013) will take place at the Sydney Convention & Exhibition Centre, Sydney, Australia from October 27 through 30, 2013.

Posted: 2013-05-22

Highlights in Management of Early Stage Non-Small Cell Lung Cancer

In August 2013, Translational Lung Cancer Research is going to launch a special issue on management of Early Stage Non-Small Cell Lung Cancer. This special issue is guest-edited by Dr.Heather Wakelee, from Stanford Cancer Institute, Stanford University, USA. The scope of the special issue will be to provide cutting-edge literature on related fields and a platform for key experts to present their latest research results.

Posted: 2013-01-29

Preview for upcoming issues on Lung Cancer: guest-edited by Rafael Rosell and Niki Karachaliou

Lung cancer remains the leading cause of cancer related mortality worldwide. With the aim of providing the most up-to-date knowledge in this field, Translational Lung Cancer Research will launch two consecutive special issues in the second quarter of 2013, dedicated to improving the management of patients with lung cancer.

Posted: 2012-11-07

Charged particle beam therapy: a new dawn for cancer treatment

Cancer is one of the leading causes of death worldwide. According to the World Health Organization (WHO), there are about 13 million new cases per year, and 8 million deaths annually, which account for 13% of all human deaths. This mortality figure is projected to rise to 12 million by 2030.

Posted: 2012-08-25

Translational Lung Cancer Research (TLCR): Call for Papers

Translational Lung Cancer Research (TLCR, Transl Lung Cancer Res, Print ISSN 2218-6751; Online ISSN 2226-4477) publishes articles that describe new findings in the field of translational research in lung cancer, provides current and practical information on diagnosis, prevention and clinical investigations of lung cancer.